Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-23-000114

Options or other derivatives

  • Director acquired 52,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hughes Owen Director 2023-11-16 Grant or award · Stock Option (Right to Buy) +52,000 52,000 D: show line 1 in the form
Loading xslF345X05/wk-form4_1700515278.xml…